This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Reassessment involves priorities, income shifts, and goal reprioritization. Consider needs, savings goals, and potential trade-offs during review.
19,137 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
A single speech by Jensen Huang can tilt markets. This article explains what these words from Jensen might mean for N...
Hewlett Packard Enterprise just blew past expectations with stronger revenue and profits, stoking the AI server rally...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
When a prominent investor trims a large stake, the market often swings. This piece breaks down what happened with Aca...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Trex's 2026 earnings narrative is shaping how investors view the decking market. This guide breaks down Q1 signals, w...
Equity traders watched the airline sector surge as oil prices fell and summer demand picked up. American Airlines led...
As fashion rental goes mainstream, rent runway (rent) 2026 will hinge on unit economics, subscriber growth, and susta...
Investors are watching whispers about Apple and Intel teaming up. This article breaks down what that could mean for s...